These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24170413)

  • 1. Unbalanced estrogen metabolism in ovarian cancer.
    Zahid M; Beseler CL; Hall JB; LeVan T; Cavalieri EL; Rogan EG
    Int J Cancer; 2014 May; 134(10):2414-23. PubMed ID: 24170413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen Metabolism in African-American Women with and without Breast Cancer: A Pilot Study.
    Zahid M; Mondal B; LeVan TD; Rogan EG
    Chem Res Toxicol; 2019 Jan; 32(1):190-194. PubMed ID: 30525503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbalanced estrogen metabolism in thyroid cancer.
    Zahid M; Goldner W; Beseler CL; Rogan EG; Cavalieri EL
    Int J Cancer; 2013 Dec; 133(11):2642-9. PubMed ID: 23686454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
    Cavalieri E; Rogan E
    Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.
    Gaikwad NW; Yang L; Weisenburger DD; Vose J; Beseler C; Rogan EG; Cavalieri EL
    Biomarkers; 2009 Nov; 14(7):502-12. PubMed ID: 19863189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel biomarkers for risk of prostate cancer: results from a case-control study.
    Yang L; Gaikwad NW; Meza J; Cavalieri EL; Muti P; Trock B; Rogan EG
    Prostate; 2009 Jan; 69(1):41-8. PubMed ID: 18816637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
    Dumas I; Diorio C
    BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular etiology of breast cancer: evidence from biomarkers of risk.
    Gaikwad NW; Yang L; Muti P; Meza JL; Pruthi S; Ingle JN; Rogan EG; Cavalieri EL
    Int J Cancer; 2008 May; 122(9):1949-57. PubMed ID: 18098283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M; Malaveille C; Hautefeuille A; Gerber M
    Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's disease.
    Gaikwad NW; Murman D; Beseler CL; Zahid M; Rogan EG; Cavalieri EL
    Biomarkers; 2011 Aug; 16(5):434-44. PubMed ID: 21692648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
    Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
    Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
    Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.
    Cavalieri EL; Rogan EG; Zahid M
    Int J Cancer; 2017 Sep; 141(6):1078-1090. PubMed ID: 28388839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells.
    Lu F; Zahid M; Wang C; Saeed M; Cavalieri EL; Rogan EG
    Cancer Prev Res (Phila); 2008 Jul; 1(2):135-45. PubMed ID: 19138946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen metabolism within the lung and its modulation by tobacco smoke.
    Peng J; Xu X; Mace BE; Vanderveer LA; Workman LR; Slifker MJ; Sullivan PM; Veenstra TD; Clapper ML
    Carcinogenesis; 2013 Apr; 34(4):909-15. PubMed ID: 23276798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
    Cavalieri E; Rogan E
    Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between genetic polymorphisms and ovarian cancer risk.
    Delort L; Chalabi N; Satih S; Rabiau N; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(5B):3079-81. PubMed ID: 19031960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
    Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation.
    Belous AR; Hachey DL; Dawling S; Roodi N; Parl FF
    Cancer Res; 2007 Jan; 67(2):812-7. PubMed ID: 17234793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.